Journal of the Practice of Cardiovascular Sciences

REVIEW ARTICLE
Year
: 2020  |  Volume : 6  |  Issue : 2  |  Page : 111--115

Myocarditis in Coronavirus disease 2019: Not an equivalent to troponinitis


Saikrishna Reddy, Bharath Kidambi, Sampath Madapati 
 Department of Cardiology, AIIMS, New Delhi, India

Correspondence Address:
Dr. Saikrishna Reddy
Department of Cardiology, AIIMS, New Delhi
India

Coronavirus disease 2019 (COVID-19) has affected around 5 million people and is on raising trend. It has overwhelmed the health-care systems of all specialties including cardiology. Cardiac involvement has been seen based on the early reports from China showing elevation of troponin and especially in the critical cases varying form 7%–28%. Speculations were made about the possibilities of myocarditis based on those reports. This short review attempted to methodologically look at available clinical evidence on the true incidence of myocarditis in COVID-19. The data suggest that troponin elevation is not equal to either ischemic heart disease or myocarditis and is some form of nonischemic myocardial injury and a marker of higher morbidity. It is related to the cytokine storm, but more information is needed on its pathogenesis.


How to cite this article:
Reddy S, Kidambi B, Madapati S. Myocarditis in Coronavirus disease 2019: Not an equivalent to troponinitis.J Pract Cardiovasc Sci 2020;6:111-115


How to cite this URL:
Reddy S, Kidambi B, Madapati S. Myocarditis in Coronavirus disease 2019: Not an equivalent to troponinitis. J Pract Cardiovasc Sci [serial online] 2020 [cited 2020 Sep 29 ];6:111-115
Available from: http://www.j-pcs.org/article.asp?issn=2395-5414;year=2020;volume=6;issue=2;spage=111;epage=115;aulast=Reddy;type=0